Literature DB >> 1666143

Anesthetic and nephrotoxic effects of Telazol in New Zealand white rabbits.

D W Brammer1, B J Doerning, C E Chrisp, H G Rush.   

Abstract

Telazol was evaluated as an anesthetic for rabbits. Two groups of five rabbits each were injected intramuscularly with 32 or 64 mg/kg of Telazol, and the depth and duration of anesthesia period monitored. At both doses, the righting reflex was lost within 2 minutes postinjection. Animals in both groups responded to noxious stimuli for the duration of the anesthesia. Hematology and urinalyses were performed daily for 7 days postinjection. Hematologic parameters remained unchanged in both groups. In the high-dose group, blood urea nitrogen and serum creatinine levels increased 1 day postinjection and continued steadily throughout the week. Elevations in urine protein and the presence of casts correlated with this increase. In the low-dose group, blood urea nitrogen and creatinine levels increased and protein was present in the urine of four of five rabbits beginning approximately 5 days postinjection. Histologically, severe renal tubular necrosis was evident 7 days postinjection in all high-dose rabbits and in three rabbits in the low-dose group. Our results indicate that Telazol does not produce analgesia in rabbits and is nephrotoxic at both 32 and 64 mg/kg. We conclude that Telazol is contraindicated for use in rabbits.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1666143

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  2 in total

1.  [Anesthesia of the New Zealand rabbit using the the combination of tiletamine-zolazepam and ketamine-midazolam with or without xylazine].

Authors:  J Dupras; P Vachon; S Cuvelliez; D Blais
Journal:  Can Vet J       Date:  2001-06       Impact factor: 1.008

2.  Transcranial direct current stimulation for balance and gait in repetitive mild traumatic brain injury in rats.

Authors:  Jee Hyun Suh; Soo Jeong Han; Gahee Park
Journal:  BMC Neurosci       Date:  2021-04-17       Impact factor: 3.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.